Total Funding
52
25
Total FundingSeries C raised
Growth Score
-3 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
44714
Evergreen Theragnostics is a contract development and manufacturing platform that provides radiopharmaceutical development services.
- James Cook: Chief Executive Officer & Founder
Serge Lyashchenko: SENIOR ADVISOR & CO-FOUNDER
About the Company
Evergreen Theragnostics is a contract development and manufacturing platform that provides radiopharmaceutical development services.
Founded in 2019, Evergreen Theragnostics rose to prominence as a notable Contract Development and Manufacturing Organization (CDMO) specializing in radiopharmaceuticals within the United States. Benefiting from an
unmatched team with extensive expertise and a demonstrated track record in theragnostic radiopharmaceutical commercialization, advancement of manufacturing processes, and management of regulatory affairs, the organization stands as an ideal partner for radiopharmaceutical development, manufacturing, and commercialization needs.
